EndoC-βH1 cell line, treated with 50 U/mL Interleukin-1 beta for 86400 seconds

EndoC-βH1 cell line, treated with 0 μM HEK293

EndoC-βH1 cell line, treated with 0 μM lentiCRISPRv2

EndoC-βH1 cell line, treated with 0 μM NLRC5 for 8 hours, 2000 U/mL Interferon alpha for 8 hours

EndoC-bH2 cell line, treated with 35 mM Glucose for 72 hours

EndoC-bH3 cell line, treated with 1 mM 4-hydroxy tamoxifen for 21 days

EndoC-βH1 cell line, treated with 1000 U/mL Tumor necrosis factor for 86400 seconds

EndoC-βH1 cell line, treated with 0 μM SRRM3

EndoC-βH1 cell line, treated with 0 μM METTL14

EndoC-βH1 cell line, treated with 2 μM dexamethasone for 86400 seconds

EndoC-βH1 cell line, treated with 0 μM negative control siRNA

EndoC-βH1 cell line, treated with 0 μM negative control siRNA

EndoC-βH1 cell line, treated with 0 μM SIX2

EndoC-βH1 cell line, treated with 0 μM TNF

EndoC-βH1 cell line, treated with 0 μM SIX3

EndoC-bH3 cell line, treated with 0 μM A1CF, 0 μM Cas9 RNP

EndoC-βH1 cell line, treated with 0 μM SPOCK2

B cell line

EndoC-βH1 cell line, treated with 0 μM non-targeting shRNA

EndoC-βH1 cell line, treated with 0 μM stromal cell

EndoC-βH1 cell line, treated with 0 μM negative control siRNA for 24 hours, 2000 U/mL Interferon alpha for 24 hours

EndoC-bH2 cell line, treated with 20 mM Glucose for 72 hours

EndoC-βH1 cell line, treated with 0 μM STAT3

EndoC-βH1 cell line, treated with 1000 U/mL Interleukin-1 beta for 48 hours, 50 U/mL Interferon gamma for 48 hours

EndoC-βH1 cell line, treated with 0 μM negative control siRNA for 72 hours